Abstracts are available to the public on PubMed*, use the links below for the abstract for each article. For full articles, refer to each journal and volume cited.

  1. Nature Medicine, March 2007, Volume 13, Number 3, pp 348-353.
    ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of Androgen receptor

  2. Journal of National Cancer Institute, April 4, 2007, Vol. 99, Issue 7: pp558-568
    Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

  3. Gastroenerology, 2008; Vol. 135, No. 3: pp 947-955
    Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma

  4. Oncogene, June 2010, Volume 29, Number 25, pp 3593-604. Epub 2010 May 3
    Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

  5. Science Translational Medicine, May 2010, Volume 2, Issue 32, pp 32ra35
    Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription

  6. The Journal of Clinical Investigation, December 2009, Volume 119, Issue 12, pp 3739-51. doi: 10.1172/JCI39335. Epub 2009 Nov 9
    Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression



*PubMed ( is a service of the U.S. National Library of Medicine and the National Institutes of Health

Home | Corporate Overview | Product Pipeline | Science & Technology | News & Events | Contact Us | Privacy Policy